Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - ACQUISITION OF F-STAR THERAPEUTICS, INC.2022.06.23
-
ADJUSTMENT TO CONVERSION PRICE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 20252022.06.17
-
VOLUNTARY ANNOUNCEMENT CATEGORY 1 INNOVATIVE DRUG “TQC2938” INJECTION APPROVED FOR CLINICAL TRIAL2022.06.14
-
NEXT DAY DISCLOSURE RETURN2022.06.08
-
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 6 JUNE 20222022.06.06
-
AMENDED AND RESTATED ARTICLES OF ASSOCIATION2022.06.06
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 20222022.06.01
-
2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT2022.05.31